New Delhi, April 1 Marksans Pharma Ltd announced on Wednesday that it has received final approval from the US health regulator for its generic version of Benzonatate capsules, indicated for the treatment of persistent cough, bronchitis, pneumonia, or other lung infections.The approval from the...
Lupin Receives Tentative USFDA Approval for Generic Pitolisant Tablets
New Delhi, March 25 – Lupin Ltd announced on Wednesday that it has received tentative approval from the US health regulator for its generic version of Pitolisant tablets, indicated for the treatment of excessive daytime...
abbreviated new drug application
drug development
drug manufacturing
excessive daytime sleepiness
generic pharmaceuticals
healthcare
india
lupin ltd
nagpur
pharmaceutical approval
pharmaceutical industry
pitolisant
regulatory filings
tablet
usfoodanddrugadministration (usfda)
Cipla’s US Arm Recalls Over 400 Cartons of Generic Anti Cancer Drug Nilotinib: USFDA
Manufacturing Issue Triggers Recall of Nilotinib Capsules in Two Strengths
New Delhi, March 8: Cipla’s US-based subsidiary has recalled more than 400 cartons of a generic anti cancer medication from the United...
anti-cancer medicine
cancer treatment
cipla
generic medicine
generics market
india
manufacturing issue
nilotinib
pharmaceutical industry
pharmaceutical manufacturing
pharmaceutical recall
sun pharmaceutical industries
united states
usfoodanddrugadministration (usfda)
warren, new jersey
USFDA Concludes Pre Approval Inspection at Enzene Biosciences Unit
New Delhi, February 16: Alkem Laboratories on Monday said the United States health regulator has issued a Form 483 with six observations following an inspection of the manufacturing facility of its wholly owned subsidiary Enzene...
alkem laboratories
bse
chakan
data integrity
drug firm
enzene biosciences
fd&c act
form 483
india
manufacturing unit
pharmaceutical industry
pharmaceutical manufacturing
quality systems
regulatory inspection
usfoodanddrugadministration (usfda)